Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andressa Dias Costa, M.D.

Concepts (86)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andressa Dias Costa's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andressa Dias Costa has written about over time.
Cell Lineage, 1 publications between 2020 and 2020, average publication date May 2020. Receptor, IGF Type 1, 1 publications between 2020 and 2020, average publication date May 2020. Microsatellite Instability, 2 publications between 2020 and 2020, average publication date June 2020. Lymphocytes, Tumor-Infiltrating, 4 publications between 2020 and 2021, average publication date November 2020. Myeloid Cells, 1 publications between 2020 and 2020, average publication date November 2020. Fusobacterium Infections, 1 publications between 2021 and 2021, average publication date February 2021. Fusobacterium nucleatum, 1 publications between 2021 and 2021, average publication date February 2021. T-Lymphocyte Subsets, 1 publications between 2021 and 2021, average publication date February 2021. Colorectal Neoplasms, 8 publications between 2020 and 2022, average publication date March 2021. Leukocytes, 1 publications between 2021 and 2021, average publication date March 2021. Granulocytes, 1 publications between 2021 and 2021, average publication date March 2021. Monocytes, 1 publications between 2021 and 2021, average publication date March 2021. HLA-DR Antigens, 2 publications between 2021 and 2021, average publication date June 2021. Tumor Microenvironment, 11 publications between 2020 and 2023, average publication date August 2021. Natural Killer T-Cells, 1 publications between 2021 and 2021, average publication date December 2021. Pancreatic Neoplasms, 9 publications between 2020 and 2024, average publication date January 2022. Carcinoma, Pancreatic Ductal, 8 publications between 2020 and 2024, average publication date February 2022. Neoadjuvant Therapy, 3 publications between 2021 and 2023, average publication date October 2022. Adenocarcinoma, 2 publications between 2022 and 2023, average publication date May 2023.

To see the data from this visualization as text, click here.
Dias Costa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.